Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ketodeoxynononic acid sialylation is present on human prostate-specific antigen

ABSTRACT: Ketodeoxynononic acid sialylation is present on human prostate-specific antigen Wei Wang1, Tao Zhang1, Jan Nouta1, Peter A. van Veelen1, Noortje de Haan1,2, Theo M. de Reijke3, Manfred Wuhrer1, Guinevere S.M. Lageveen-Kammeijer1*

INSTRUMENT(S): mass spectrometry

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Guinevere S.M. Lageveen-Kammeijer

PROVIDER: MSV000089140 | MassIVE | Tue Mar 29 02:10:00 BST 2022

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Profiling the Proteoforms of Urinary Prostate-Specific Antigen by Capillary Electrophoresis - Mass Spectrometry

Project description:This data set contains all raw data files in the mzXML format that belongs to the manuscript: Profiling the Proteoforms of Urinary Prostate Specific Antigen by Capillary Electrophoresis Mass Spectrometry, by Alan B. Moran, Elena Dominguez Vega, Jan Nouta, Tamas Pongracz, Theo M. de Reijke, Manfred Wuhrer and Guinevere S.M. Lageveen-Kammeijer.

2021-01-15 | MSV000086699 | MassIVE

Profiling the Proteoforms of Urinary Prostate-Specific Antigen by Capillary Electrophoresis - Mass Spectrometry

2021-01-18 | MSV000086715 | MassIVE

Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples

Project description:This data set contains all raw data files in the mzXML (for CE-ESI-MS data) or xy (for MALDI-TOF-MS data) format that belongs to the manuscript "Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples" by Guinevere S.M. Lageveen-Kammeijer, Noortje de Haan, Pablo Mohaupt, Sander Wagt, Mike Filius, Jan Nouta, David Falck and Manfred Wuhrer.

2019-02-25 | MSV000083478 | MassIVE

Competition or indifference: Neutron-Encoding to profile linkage selectivity of deubiquitinating enzymes

Project description:This data set contains all raw data files in the mzXML (for LC-MS data) format that belongs to the manuscript "Competition or indifference: Neutron-Encoding to profile linkage selectivity of deubiquitinating enzymes" by Bianca D. M. van Tol, Bjorn R. van Doodewaerd, Guinevere S. M. Lageveen-Kammeijer, Bas C. Jansen, Cami M. P. Talavera Ormeno, Paul J. M. Hekking, Aysegul Sapmaz, Robbert Q. Kim, Angeliki Moutsiopoulou, David Komander, Manfred Wuhrer, Gerbrand J. van der Heden van Noort, Huib Ovaa, Paul P. Geurink

2022-10-05 | MSV000090455 | MassIVE

mRNA expression data of 62 human medulloblastoma tumors

Project description:To identify molecular subtypes of medulloblastoma we have profiled a series of 62 medulloblastoma tumors. Unsupervised hierarchical cluster analysis of these data identified 5 distinct molecular subtypes. Manuscript submitted. Title: Identification of medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. Authors: Marcel Kool, Jan Koster, Jens Bunt, Nancy E. Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten – van Meeteren, Huib N. Caron, Alan Mršić, Bauke Ylstra, Wieslawa Grajkowska, Wolfgang Hartmann, Torsten Pietsch, David Ellison, Steven C. Clifford, Rogier Versteeg. Keywords: tumor classification

2008-09-02 | GSE10327 | GEO

mRNA expression data of 62 human medulloblastoma tumors

Project description:To identify molecular subtypes of medulloblastoma we have profiled a series of 62 medulloblastoma tumors. Unsupervised hierarchical cluster analysis of these data identified 5 distinct molecular subtypes. Manuscript submitted. Title: Identification of medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. Authors: Marcel Kool, Jan Koster, Jens Bunt, Nancy E. Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten â van Meeteren, Huib N. Caron, Alan MrÅ¡iÄ, Bauke Ylstra, Wieslawa Grajkowska, Wolfgang Hartmann, Torsten Pietsch, David Ellison, Steven C. Clifford, Rogier Versteeg. Keywords: tumor classification 62 human medulloblastoma samples were analzyed

2008-09-02 | E-GEOD-10327 | biostudies-arrayexpress

Molecular markers in the CSF proteome differentiate neuroinflammatory diseases

2021-02-22 | PXD017643 | Pride

A pilot study evaluating response to induction chemotherapy with oxaliplatin, capecitabine and bevacizumab in patients with extensive peritoneal carcinomatosis of colorectal origin.

Project description:Primary end point will be the assessment of macroscopic and microscopic response. Primary endpoints: Het primaire objectief voor deze studie is:- Het onderzoeken van de response rate en de macroscopische en microscopische responskenmerken van neo-adjuvante chemotherapie in patiënten met peritoneale carcinomatose (PC) van colorectale oorsprong.

| 2527556 | ecrin-mdr-crc

Molecular markers in the CSF proteome differentiate neuroinflammatory diseases

Project description:Manuscript "Molecular markers in the CSF proteome differentiate neuroinflammatory diseases" by Maria L. Elkjaer Arkadiusz Nawrocki, Tim Kacprowski, Anja Hviid Simonsen, Romain Marignier, Tobias Sejbaek, Helle H. Nielsen, Lene Wermuth, Peter Høgh, Finn Sellebjerg, Richard Reynolds, Jan Baumbach, Martin R. Larssen, Zsolt Illes (prepared for submission). Validation of differences in protein abundance, found in the discovery phase of the project (comparison of pools of respective samples), by analysis of proteomes of individual samples enrolled.

2022-08-08 | PXD017681 | Pride

Prostate-specific membrane antigen-targeted theranostics: past, present, and future approaches.

Project description:Although prostate cancer is the type of cancer most commonly survived by men in the United States, it remains the second most common cause of death from cancer, largely owing to metastatic disease. Patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed on standard-of-care therapies have few options and a poor prognosis. Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein that is commonly expressed in prostate cancer. Expression is limited on extra-prostatic tissues other than the salivary glands, lacrimal glands, duodenal epithelium, Kupffer cells, and renal tubules. PSMA-directed theranostics has emerged to exploit the specificity of PSMA for prostate cancer cells and has demonstrated promising results in the clinic. Radionuclides linked to PSMA inhibitors/binders have resulted in US Food and Drug Administration (FDA) approval of 2 radiodiagnostics for PSMA-directed positron emission tomography/computed tomography. In addition, these radionuclides have led to the development of lutetium Lu 177PSMA-617 therapy, which is currently under priority FDA review. Multiple novel PSMA-targeted modalities have been developed and are currently under clinical investigation, including ligand-drug and cellular immune therapies. In this review, we discuss the development of PSMA-directed theranostics, along with its clinical implications, limitations, and future directions.

| S-EPMC9423035 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data